Nanosphere receives FDA clearance to market its CYP2C19

theflyonthewall.com

Nanosphere announced the U.S. FDA granted 510k clearance permitting marketing of its CYP2C19 Nucleic Acid Test, or CYP2C19 Test, on the automated sample-to-result Verigene System.

View Comments (0)